Advertisement
Advertisement
SGHT
Sight Sciences, Inc. Common Stock
7.47
USDSponsored
+0.38
+5.36%
Aug 07, 15:59 UTC -4
Closed
After-Market
7.48
+0.01
+0.13%
SGHT Earnings Reports
Positive Surprise Ratio
SGHT beat 13 of 21 last estimates.
62%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$22.45M
/-$0.14
Implied change from Q2 26 (Revenue/ EPS)
-4.03%
/+75.00%
Implied change from Q3 25 (Revenue/ EPS)
+12.77%
/-12.50%
Sight Sciences, Inc. Common Stock earnings per share and revenue
On Aug 05, 2026, SGHT reported earnings of -0.08 USD per share (EPS) for Q2 26, beating the estimate of -0.15 USD, resulting in a 49.14% surprise. Revenue reached 23.39 million, compared to an expected 22.12 million, with a 5.76% difference. The market reacted with a +27.75% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of -0.14 USD, with revenue projected to reach 22.45 million USD, implying an increase of 75.00% EPS, and decrease of -4.03% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.31
Surprise
+4.94%
Artivion, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.01
Actual
$0.13
Surprise
+1,174.51%
Delcath Systems Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
$0.07
Surprise
+176.25%
Treace Medical Concepts, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.30
Actual
-$0.24
Surprise
+21.05%
Inogen Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.14
Surprise
+10.88%
CVRx, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.53
Actual
-$0.53
Surprise
+0.90%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.27
Surprise
-8.78%
Hyperfine, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+1.96%
GLOBUS MEDICAL INC
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.12
Actual
$1.34
Surprise
+19.50%
Teleflex Incorporated
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.29
Actual
$1.76
Surprise
+36.04%
FAQ
What were Sight Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Sight Sciences, Inc. Common Stock reported EPS of -$0.08, beating estimates by 49.14%, and revenue of $23.39M, 5.76% above expectations.
How did the market react to Sight Sciences, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 27.75%, changed from $5.55 before the earnings release to $7.09 the day after.
When is Sight Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Sight Sciences, Inc. Common Stock's next earnings report?
Based on 9
analysts, Sight Sciences, Inc. Common Stock is expected to report EPS of -$0.14 and revenue of $22.45M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement